Eric Pauwels - 14 Mar 2025 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Signature
/s/ Avraham S. Adler, Attorney-in-Fact
Issuer symbol
PTCT
Transactions as of
14 Mar 2025
Net transactions value
-$630,104
Form type
4
Filing time
18 Mar 2025, 17:20:05 UTC
Previous filing
21 Feb 2025
Next filing
09 Sep 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTCT Common Stock Sale $246,037 -4,458 -5.3% $55.19 79,402 14 Mar 2025 Direct F1, F2
transaction PTCT Common Stock Sale $112,524 -2,037 -2.6% $55.24 77,365 17 Mar 2025 Direct F1, F3
transaction PTCT Common Stock Sale $61,433 -1,085 -1.4% $56.62 76,280 17 Mar 2025 Direct F1, F4
transaction PTCT Common Stock Sale $192,618 -3,340 -4.4% $57.67 72,940 17 Mar 2025 Direct F1, F5
transaction PTCT Common Stock Sale $17,493 -300 -0.41% $58.31 72,640 17 Mar 2025 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 13, 2024.
F2 This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $55.00 to $55.49 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3 This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $55.00 to $55.98 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F4 This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $56.20 to $57.14 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F5 This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $57.30 to $58.26 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F6 This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $58.30 to $58.31 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.